absorption in the intestine of patients with Hartnup disease. A more generalized malabsorption of amino acids similar to that in the renal tubules was demonstrated subsequently by Scriver (12) . Wong and Pillai (20) showed conclusively that intra\~enously administered tryptophan was normally metabolized. On the other hand, it was shown that a patient with congenital tryptophanuria had a defect in the kynurenine pathway of tryptophan metabolism (Fig. I) . However, the exact site of the enzymatic defect was not localized (16) . This paper describes the biochemical studies in a young patient who had marked cerebellar ataxia and photosensitive skin rash. This patient, however. differed clinically from patients with Hartnup disease and congenital tryptophanuria in that he was sensitive to oral nicotinic acid therapy.
CASE STUDY
This 7-year-old Caucasian boy was admitted to the University of Illinois Hospital for investigation because of ataxia and a skin rash.
He was delivered at term and in good condition after a normal pregnancy. His birth weight was 3.5 kg and there was no complication during the neonatal period. He started to smile at 2 months: grasp ob-jects at 3 months: roll over at 5 months: sit up and say simple words at X months: stand up and crawl at I I months: walk at 14 months: and talk in "sentences" at 2 years and 10 months. At 3 years of age, he was toilet-trained.
Since he started walking at 14 months of age, he was observed to be "clumsy," with poor coordination of the hands. poor balance in walking. and frequent falls. At the age of 2 years and 10 months, he was noted to "walk on his toes" and was inclined to lean forwards while running. falling frequently. At the age of 3 years, he was able to ride a tricycle without difficulty, although his hands were unsteady, he spilled food while feeding himself with a spoon. and he had a staggering gait. These symptoms and signs of ataxia disappeared completely at various times. The intermittent gross ataxia resulted in two falls which required visits to physicians For examination with suspicion of head injury. He had stuttering of speech and excessive drooling. Since the age of 2 years. he had 2 dry. red, scaly rash on the face and the exposed areas of the arms and legs during the spring and the summer. Occasionally, blister formation was also observed. The parents quickly appreciated the association of' exposure to sunlight and the appearance of the rash which would improve when he was well covered and disappeared completely during the winter. The possibility of dietary deficiency of niacin was excluded by a careful dietary history.
From the age of 5 years, he had symptoms of allergic rhinitis, and from the age of 7 years, he had a few attacks of bronchial asthma.
His father was an Irish-American and his mother an ItalianAmerican. Both parents. his 8-year-old brother. and his 6-year-old brother were healthy.
Physical examination at the age of 7 years showed that he was small for his age. His height, weight, and head circumference were 105 cm. 17.2 kg. and 48 cm. respectively, all of which were below the third percentile. His 6-year-old brother was taller as well as heavier.
There was a marked erythematous rash on the nasal bridge, the cheeks, the malar regions. the ears, and the exposed parts of the arms and legs. Scaling and peeling were prominent on the face. N o abnormality was detected i' n the examination of the lungs, heart. and abdomen. His cranial nerves were intact. There was a mild increase of his muscular tone and spasticity of his lower limbs. but no muscular atrophy was found and muscular power was normal. Intentional tremor of upper and lower limbs was prominent but no nystagmus was observed. His gait was grossly ataxic and Romberg's sign was positive. Deep tendon reflexes were exaggerated but planter reflexes and sensory functions were normal.
Routine laboratory studies showed normal hemoglobin, white cell and differential count. serum electrolytes and blood urea nitrogen, serum glutamate-oxaloacetate and glutamate-pyruvate transaminases, lactate dehydrogenase, creatine phosphokinase, and alkaline phosphatase were within the normal range. Spina bifida occulta at the 5th lumbar vertebra was demonstrated in the x-ray of the spine. An audiogram and two electroencephalograms were entirely normal. Evaluation by a psychologist showed that his iQ was about 60. Histologic examination of a skin biopsy showed changes of a chronic nonspecific dermatitis.
METHODS
Ion exchange chromatography (10) was used for the quantitation of amino acids. Tryptophan was identified by paper chromatography using Ehrlich's reagent (15) and was quantitated by the method of Denckla and Dewey (6). Paper chromatography (15) was used for the identification of tryptophan metabolites. The (21), respectively, were employed. The method of Chen (4) was adapted for the identification and estimation of formylkynurenine. A sensitive assay of tryptophan pyrrolase was developed by modifying the method of Knox and Mehler (8) . using labeled tryptophan and 1-3 mg rat liver protein. Leukocytes were isolated from heparinized blood with dextran (14) . Skin fibroblasts were cultured hy routine methods ( 1 1). Renal clearance of tryptophan was calculated as described previously (19) . Oral tryptophan loading tests were performed in the patient and comparable control subjects (children without metabolic disorders) after overnipht fasting, using 100 mg L-tryptophanlkg body weight as described previously (20) . Venous blood was obtained at 0, 2, 4. 6, and 8 hr for the determination of tryptophan. After tryptophan loading, urine was collected every 6 hr for other chemical determinations.
Urea was removed from urine samples by purified urease obtained from the Sigma Chemical Company by a modificat~on of the method of Henry and Chiamori (7).
RESULTS
Several quantitative determinations of amino acids in 24-hr urine samples from the patient showed no evidence of hyperaminoaciduria. In addition. random urine samples did not contain excessive quantities of indoxyl sulfate. indicating that the patient did not have Hartnup disease.
The mean of three fasting plasma tryptophan determinations in the patient was 6.21 i 0.720 ~rno1/100 rnl and. that in six con- . One dinirn\lori,~l ;~\ccndln~ pap" chroni;~togran~ vl urtrlr t~ndcr t~l t r ;~v~u l i . t l l~h t 1 roril lci't t o rtglil arc \a!ilplc\ 01 c~~ntrol urine with the following markers: xanthurenic acid. kynurenic acid, kynurenine, and forniylkynurenine, respectively: 5th and 6th from the left are pre-and postloading urine samples, respectively, from a control subject: and 7th and 8th from the left are pre-and postloading urine samples. respectively, from the patient. trol subjects was 4.28 i 0.956 pmol/ 100 ml. There was no significant difference (P > 0.5). Plasma concentrations of tryptophan after tryptophan loading tests are shown in Figure 2 . In contrast to patients with Hartnup disease (20) . the levels of tryptophan at 0, 2. 4, 6. and 8 hr in the patient increased markedly. suggesting that intestinal absorption was normal. In one loading test. there was a suggestion that tryptophan clearance in the plasma might be somewhat delayed in the patient.
Urinary excretion of tryptophan after loading tests is shown in Figure 3 . From 0 to 6 and from 6 to I2 hr after loading. the patient excreted Inore tr!,ptophan than the control subjects. This may be o retlection of higher plasma tryptophan levels or increased renal loss. For this reason. renal clearance of tryptophan was calculated. Without tryptophan loading. the average renal clearance in the patient was 0.534 ml plasma/ 1.73 m'; that in three control subjects was 0.820 ml plasma/ 1.73 m2. The average renal clearance during the first 6 hr of the loading tests was not differen! in the pztient and the control subjects (0.757 ml and 0.706 ml, respectively). This indicated that there was no excessive renal loss of tryptophan in the patient. Figure 4 shows the renal excretion of kynurenine after tryptophan loading. In contrast to the two control subjects. the patient showed little increase of kynurenine excretion despite the marked increase of plasma tryptophan.
Urinary excretion of N'-methylnicotinamide in the patient after tryptophan loading was similar to that of the two control subjects (Table I) . It should be pointed out, however, that both the patient and the control subjects were given similar hospital diet for lunch and dinner after loading; the amount of exogenous nicotinamide from the diet was not quantitated.
The excretion of indoxyl sulfate after tryptophan loading in the patient was similar to that in two control subjects (Table I) . There was no marked or delayed increase, characteristic of Hartnup 2. 0 10.37 Indole-3-acetic acid (C1) (C2) (P) (P) 5-Hydroxyindoleacetic acid (C 1 ) (C2) (P) (P) ' C: control subject: P: patient.
'All values are expressed ;is micromoles per k g per 6 h r .
All values are expressed as rnicronioles per kg per 24 hr.
disease (20) . In the same manner, the excretion of indole-3-acetic acid and 5-hydroxyindole acetic acid in the patient was similar to that in the control subjects (Table I) . Urinary excretion of fluorescent metabolites after tryptophan loading tests is demonstrated in Figure 5 . Using equivalent amounts of urine based on creatinine concentrations, multiple runs of paper chromatography examined under ultraviolet light showed similar results in that the patient failed to show a significant increase of urinary xanthurenic acid, kynurenic acid, kynurenine, and formylkynurenine. T o further identify formylkynurenine, urine samples were subjected to two-dimensional paper chromatography using various solvent systems and Ehrlich's reagent for staining. In all systems used. formylkynurenine could not be separated from the large amounts of urea. Therefore, urea was removed from the urine samples by incubation with purified urease. The result is demonstrated in Figures 6 and 7 . It is seen that from 0 to 6 and from 6 to 12 hr after tryptophan loading. a control subject excreted large amounts of formylkynurenine and kynurenine (Fig. 6) . On the other hand, the patient failed to excrete significant amounts of these substances at any time after tryptophan loading (Fig. 7) .
Using L-[14C]methylene tryptophan as substrate and 1-3 mg rat liver protein, 1.6-3.5 nmol kynurenine were produced/hr/mg protein. However, using 3-4 mg white blood cell protein (approximately 50-60 x 106 cells) and 7-8 mg fibroblast protein (approximately 8 confluent flasks with surface area of 75 cm2 each) from normal subjects. no activity of tryptophan pyrrolase was detected on several occasions. Activity as little as 3 -5% of that found in rat liver should be detectable by this method.
Treatment with 100 mg, 50 mg, and 10 mg nicotinic acid in the patient resulted in flushing. "burning" sensation, and "itching" of skin. On the other hand, treatment with 50 mg o r 100 mg of nicotinamide did not produce any untoward effect. but the photosensitive. pellagra-like skin rash did not appear during prolonged exposure to sunlight while the patient was in a summer camp. However, there was no change in the neurologic abnormalities.
Because of the possibility of an interaction between nicotinic acid and serotonin, blood concentration of serotonin was determined on two occasions without any medication or tryptophan loading. The patient had 0.32 and 0.30 pg serotonin/ml blood and three control subjects had 0.20, 0.3 I . and 0.27 pg/ml, respectively. These results are similar to reported values. There was no evidence of increased serotonin in the blood of the patient.
DISCUSSION
Hartnup disease is characterized biochemically by hyperaminoaciduria, excessive indicanuria. and malabsorption of tryptophan (9) . The latter may be demonstrated by a lack of increase or small increase in plasma tryptophan after an oral tryptophan loading test (20) . The decrease of kynurenine and N'-methylnicotinamide excretion and the excessive increase of indole-3-acetic acid and indoxyl sulfate (indican) excretion may also be explained on the basis of tryptophan malabsorption (I). O n the other hand, intravenously administered tryptophan is normally metabolized (20) . indicating that there is no defect in the intracellular metabolism of tryptophan.
In our patient, intestinal malabsorption of tryptophan can be excluded by the marked increase of plasma tryptophan after oral tryptophan loading and by the lack of excessive excretion of indoxyl sulfate and 5-hydroxyindole acetic acid. In addition, the absence of hyperaminoaciduria and the normal renal clearance of tryptophan effectively exclude Hartnup disease in this patient. Therefore, the decreased excretion of kynurenine requires a different explanation. After tryptophan loading, the absence of Fig. 6 . One-dimensional ascending paper chromatography of urine samples stained with Ehrlich's reagent from a control subject. P: preloading urine; P i K: preloading urine plus kynurenine marker; P + FK: preload~nz urine plus formylkynurenine and kynurenine markers; 0-6, 6-12, 12-18, 18-24: urine samples obtained after tryptophan loading for the respective periods. O r a l administration of nicotinic acid in small doses ~r o d u c e d 11 . Paul, J.: In: Cell and Tissue Culture (The Williams & Wilkins Co., Inc.. flushing, "burning," and "itching" of the skin but oral nicotinamide was well tolerated, resulting in improvement of the photosensitive skin rash.
